Original Article

Survey of Knowledge and Attitude of Pharmacists about Direct Oral Anticoagulants: A Cross-Sectional Study


Background: Direct oral anticoagulants (DOACs) are increasingly used due to fewer side effects, predictable pharmacokinetics, lower potential for drug interactions. Different levels of awareness among health care professionals have been reported.Methods: The main objectives of this study were to investigate the knowledge and attitude of pharmacists about direct oral anticoagulants. The present study was a descriptive cross-sectional study performed in Kermanshah province, Iran. The validated researcher-made questionnaire included questions about demographic characteristics and specialized questions that assessed the knowledge and attitude of pharmacists towards new oral anticoagulants. Results: Out of 126 pharmacists participating in this study, 67 (53.2%) were male. The mean scores of knowledges and attitude in pharmacists were 64.94±5.84 and 28.62±3.98, respectively. The most common oral anticoagulant with a direct effect dispensed by pharmacists was rivaroxaban (77.4%). There was also a significant relationship between pharmacists' attitudes and their place of activity (P = 0.024).Conclusion: The results of this study showed that pharmacists had an acceptable knowledge and low attitude about DOACs.

1. Jiménez D, Bikdeli B, Quezada A, et al. Hospital volume and outcomes for acute pulmonary embolism: multinational population based cohort study. BMJ 2019;366.
2. Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur J Cardiothorac Surg 2016;50(5):e1-e88.
3. Krijthe BP, Kunst A, Benjamin EJ, et al. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J 2013;34(35):2746-51.
4. January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2019;74(1):104-32.
5. El-Bardissy A, Elewa H, Mohammed S, Shible A, Imanullah R, Mohammed AM. A survey on the awareness and attitude of physicians on direct oral anticoagulants in Qatar. Clin Appl Thromb Hemost 2018;24(9_suppl):255S-60S.
6. Elewa H, El-Makaty H, Ali Z. Appropriateness of dabigatran and rivaroxaban prescribing in Qatar: a 5-year experience. J Cardiovasc Pharmacol Ther 2018;23(2):155-61.
7. Ashjian E, Kurtz B, Renner E, Yeshe R, Barnes GD. Evaluation of a pharmacist-led outpatient direct oral anticoagulant service. Am J Health-Syst Pharm 2017;74(7):483-9.
8. Manzoor BS, Cheng WH, Lee JC, Uppuluri EM, Nutescu EA. Quality of pharmacist-managed anticoagulation therapy in long-term ambulatory settings: a systematic review. Ann Pharmacother 2017;51(12):1122-37.
9. Zdyb EG, Courtney DM, Malik S, Schmidt MJ, Lyden AE. Impact of discharge anticoagulation education by emergency department pharmacists at a tertiary academic medical center. J Emerg Med 2017;53(6):896-903.
10. Ingram SJ, Kirkdale CL, Williams S, et al. Moving anticoagulation initiation and monitoring services into the community: evaluation of the Brighton and hove community pharmacy service. BMC Health Serv Res 2018;18(1):1-7.
11. Harrison J, Shaw JP, Harrison JE. Anticoagulation management by community pharmacists in N ew Z ealand: an evaluation of a collaborative model in primary care. Int J Pharm Prac 2015;23(3):173-81.
12. Aquilina A, Wirth F, Attard Pizzuto M, et al. Preparing for pharmacist prescribing in Maltese hospitals. J Pharm Health Serv Res 2018;9(3):237-43.
13. El-Bardissy A, Elewa H, Khalil A, et al. Assessing Pharmacists Knowledge and Attitude Toward the Direct Oral Anticoagulants in Qatar. Clin Appl Thromb Hemost 2020;26:1-7.
14. Steffel J, Verhamme P, Potpara TS, et al. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Heart J 2018;39(16):1330-93.
15. Roederer MW, Van Riper M, Valgus J, Knafl G, McLeod H. Knowledge, attitudes and education of pharmacists regarding pharmacogenetic testing. Per Med 2012;9(1):19-27.
16. Eljilany I, El-Bardissy A, Nemir A, et al. Assessment of the attitude, awareness and practice of periprocedural warfarin management among health care professional in Qatar. A cross sectional survey. J Thromb Haemost 2020;50(4):957-68.
17. Sandhu RK, Guirguis LM, Bungard TJ, et al. Evaluating the potential for pharmacists to prescribe oral anticoagulants for atrial fibrillation. Can Pharm J 2018;151(1):51-61.
18. Papastergiou J, Kheir N, Ladova K, et al. Pharmacists’ confidence when providing pharmaceutical care on anticoagulants, a multinational survey. Int J Clin Pharm 2017;39(6):1282-90.
19. Hanafi S, Poormalek F, Torkamandi H, et al. Evaluation of community pharmacists’ knowledge, attitude and practice towards good pharmacy practice in Iran. J Pharm Care 2013;1(1):19-24.
IssueVol 9, No 3 (Summer 2021) QRcode
SectionOriginal Article(s)
DOI https://doi.org/10.18502/jpc.v9i3.7369
Attitude; Direct Oral Anticoagulants; Knowledge

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
Vakili Z, Heydarpour F, Shahbazi F. Survey of Knowledge and Attitude of Pharmacists about Direct Oral Anticoagulants: A Cross-Sectional Study. J Pharm Care. 2021;9(3):114-118.